The European Medicines Agency is working on an initiative to establish a common protocol, or a minimum set of requirements, for registries for CAR-T cells that are regulated as advanced therapy medicinal products (ATMPs) in the EU.
The initiative will include the EMA hosting a registries workshop that will result in a report "summarising the discussions of...